These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 6811658)
1. The human HLA-DR antigens are encoded by multiple beta-chain loci. Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658 [TBL] [Abstract][Full Text] [Related]
2. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure. Alexander S; Hubbard SC; Strominger JL J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984 [TBL] [Abstract][Full Text] [Related]
3. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies. Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353 [TBL] [Abstract][Full Text] [Related]
4. [HLA-DR antigens: cellular expression and molecular structure]. Charron DJ Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269 [TBL] [Abstract][Full Text] [Related]
5. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. Matsuyama T; Schwenzer J; Silver J; Winchester R J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991 [TBL] [Abstract][Full Text] [Related]
6. Analysis of DR-like molecules on a marmoset Epstein-Barr virus-induced cell line using a monomorphic anti-human HLA-DR monoclonal antibody. Teillaud JL; Charron D; Goujet-Zalc C; Mahouy G Eur J Immunol; 1982 May; 12(5):446-8. PubMed ID: 6284521 [TBL] [Abstract][Full Text] [Related]
7. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus. De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens. Kasahara M; Ikeda H; Ogasawara K; Ishikawa N; Okuyama T; Fukasawa Y; Kojima H; Kunikane H; Hawkin S; Ohhashi T Immunology; 1984 Sep; 53(1):79-86. PubMed ID: 6205985 [TBL] [Abstract][Full Text] [Related]
9. The extracellular region of light chains from human and murine MHC class II antigens consists of two domains. Kaufman JF; Strominger JL J Immunol; 1983 Feb; 130(2):808-17. PubMed ID: 6401306 [TBL] [Abstract][Full Text] [Related]
10. Analysis of structural properties and cellular distribution of avian Ia antigen by using monoclonal antibody to monomorphic determinants. Ewert DL; Munchus MS; Chen CL; Cooper MD J Immunol; 1984 May; 132(5):2524-30. PubMed ID: 6201548 [TBL] [Abstract][Full Text] [Related]
11. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. Adams TE; Bodmer JG; Bodmer WF Immunology; 1983 Dec; 50(4):613-24. PubMed ID: 6197354 [TBL] [Abstract][Full Text] [Related]
12. Biochemical analysis of class II antigens. Identification of a two- and a three-polypeptide chain complex of I-A locus equivalent molecules in the rat. Bayer J; Reske K Eur J Immunol; 1983 Jan; 13(1):18-24. PubMed ID: 6403353 [No Abstract] [Full Text] [Related]
13. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies. Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545 [TBL] [Abstract][Full Text] [Related]
14. N-terminal amino acid sequence analyses of the alpha and beta polypeptides from four distinct subsets of sheep major histocompatibility complex class II molecules. Puri NK; Walker ID; Brandon MR J Immunol; 1987 Nov; 139(9):2996-3002. PubMed ID: 3478413 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression. Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957 [TBL] [Abstract][Full Text] [Related]
16. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548 [TBL] [Abstract][Full Text] [Related]
17. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines. Maeda H; Hirata R J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807 [TBL] [Abstract][Full Text] [Related]
18. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. Giles RC; Nunez G; Hurley CK; Nunez-Roldan A; Winchester R; Stastny P; Capra JD J Exp Med; 1983 May; 157(5):1461-70. PubMed ID: 6189938 [TBL] [Abstract][Full Text] [Related]
19. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire. Batten P; Heaton T; Fuller-Espie S; Lechler RI J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511 [TBL] [Abstract][Full Text] [Related]
20. Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity. Gorski J; Mach B Nature; 1986 Jul 3-9; 322(6074):67-70. PubMed ID: 3459965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]